IgM-mediated enhancement of in vivo anti-sheep erythrocyte antibody responses: isotype analysis of the enhanced responses.
The direct splenic anti-sheep erythrocyte (anti-SRBC) responses as well as the serum IgG1, IgG2a, IgG2b, and IgG3 anti-SRBC responses of CBA/CaJ mice were monitored 4-35 days after immunization with: (1) a suboptimal dose of SRBC, (2) a suboptimal dose of SRBC plus monoclonal IgM anti-SRBC, or (3) a high dose of SRBC. The direct plaque-forming cell (PFC) responses of mice in treatment group 2 were significantly higher than those in group 1 but similar to the responses in group 3. The serum anti-SRBC antibody responses of all IgG subclasses were significantly enhanced by IgM anti-SRBC and were generally even higher than the responses obtained with high doses of SRBC. The relative proportions of each serum IgG subclass were similar in all three groups. These data suggest that the enhancement of suboptimal anti-SRBC antibody responses by IgM anti-SRBC extends through IgM and all of the IgG subclasses and, further, that the isotype profile in antibody-enhanced responses is similar to that obtained with high doses of SRBC.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000502:physiology; D001789:Blood Group Antigens / Q000276:immunology*; D004306:Dose-Response Relationship, Immunologic; D006462:Hemolytic Plaque Technique; D007126:Immunoglobulin Allotypes / Q000096:biosynthesis* / Q000145:classification; D007074:Immunoglobulin G / Q000096:biosynthesis; D007075:Immunoglobulin M / Q000008:administration & dosage / Q000502:physiology*; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D012756:Sheep / Q000276:immunology
D000911:Antibodies, Monoclonal; D001789:Blood Group Antigens; D007126:Immunoglobulin Allotypes; D007074:Immunoglobulin G; D007075:Immunoglobulin M